scholarly journals Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial

2020 ◽  
Vol 16 (1) ◽  
Author(s):  
Donald S. Levy ◽  
Henriette Farkas ◽  
Marc A. Riedl ◽  
Florence Ida Hsu ◽  
Joel P. Brooks ◽  
...  
Keyword(s):  
Subgroup Analysis ◽  
Hereditary Angioedema ◽  
Efficacy And Safety ◽  
C1 Inhibitor ◽  
Open Label ◽  
Phase 3 ◽  
Term Efficacy ◽  
Open Label Extension

scholarly journals Long-term efficacy and safety of migalastat treatment in Fabry disease: 30-month results from the open-label extension of the randomized, phase 3 ATTRACT study

2020 ◽  
Vol 131 (1-2) ◽  
pp. 219-228 ◽  
Author(s):  
Ulla Feldt-Rasmussen ◽  
Derralynn Hughes ◽  
Gere Sunder-Plassmann ◽  
Suma Shankar ◽  
Khan Nedd ◽  
...  
Keyword(s):  
Fabry Disease ◽  
Efficacy And Safety ◽  
Open Label ◽  
Phase 3 ◽  
Term Efficacy ◽  
Open Label Extension

scholarly journals Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study

2022 ◽  
Vol 239 ◽  
pp. 83-91
Author(s):  
Yuriy Filts ◽  
Robert E. Litman ◽  
Javier Martínez ◽  
Lourdes Anta ◽  
Dieter Naber ◽  
...  
Keyword(s):  
Extension Study ◽  
Efficacy And Safety ◽  
Open Label ◽  
Term Efficacy ◽  
Open Label Extension

P150 LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY

2020 ◽  
Vol 125 (5) ◽  
pp. S21
Author(s):  
A. Banerji ◽  
J. Hao ◽  
M. Yu ◽  
J. Bernstein ◽  
D. Johnston ◽  
...  
Keyword(s):  
Extension Study ◽  
Efficacy And Safety ◽  
Open Label ◽  
Term Efficacy ◽  
Open Label Extension
Sign in / Sign up

Export Citation Format

Share Document